Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Triangle Ventures (RTV) is a venture capital firm based in Raleigh, North Carolina, that specialized in seed and early-stage investments in technology and life sciences. Founded in 2000, the firm focused on emerging, high-growth companies within the Research Triangle region, including sectors such as biotechnology, medical devices, and software. RTV played a significant role in the local startup ecosystem, backing companies like Tranzyme Pharma and AlphaVax. As of recent reports, the firm is no longer actively making new investments and is focused on managing its remaining portfolio toward exit. The firm was founded by Tim C. Gupton and Bud Whitmeyer and has been a key contributor to the development of the life sciences cluster in North Carolina.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Triangle Ventures.